Literature DB >> 6614892

Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functions.

H Ohnishi, H Kosuzume, H Inaba, M Okura, H Mochizuki, Y Suzuki, R Fujii.   

Abstract

The effects of a new semisynthetic cephalosporin, AC-1370, on phagocyte functions were compared with those of cefoperazone. AC-1370 augmented phagocytosis by mouse macrophages in vitro and in vivo, by mouse neutrophils in vivo, and by human neutrophils in vitro. Cefoperazone suppressed phagocytosis by mouse macrophages and neutrophils. Random migration and chemotaxis of mouse and human neutrophils were increased by the addition of AC-1370. Nitroblue tetrazolium reduction by human neutrophils was enhanced by the addition of AC-1370. Intracellular killing of bacteria by macrophages was also enhanced by AC-1370. Further, bactericidal effects of AC-1370 against Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae were augmented when they were each cultured with mouse or human leukocytes. These results suggest that AC-1370 is an unique beta-lactam antibiotic which has a potentiating effect on phagocyte functions as well as a bactericidal effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6614892      PMCID: PMC184990          DOI: 10.1128/AAC.23.6.874

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Sensitive and quantitative nitroblue-tetrazolium test for detecting chronic granulomatous disease.

Authors:  N Okamura; T Takano; S Ishibashi; D Amano; T Usui
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-09       Impact factor: 1.645

Review 3.  Acute infections in cancer patients.

Authors:  S J Ketchel; V Rodriguez
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

4.  Opportunistic infection.

Authors:  H Smith
Journal:  Br Med J       Date:  1973-04-14

5.  Complement response after experimental bacterial infection in various nutritional states.

Authors:  M Sakamoto; S Ishii; K Nishioka; K Shimada
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

6.  Role of antibody in infections due to Pseudomonas aeruginosa.

Authors:  L S Young
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

Review 7.  Opportunistic infection: a review.

Authors:  A S Klainer; W R Beisel
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

8.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.

Authors:  A B Bjornson; J G Michael
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Effects of anti-infectious agents on polymorphonuclear neutrophils.

Authors:  M T Labro; J el Benna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 2.  Immunomodulation by antibacterial agents. Is it clinically relevant?

Authors:  M T Labro
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

3.  Mechanism of action of AC-1370 on phagocyte functions.

Authors:  H Ohnishi; H Inaba; H Mochizuki; H Kosuzume
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

4.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.

Authors:  G Gialdroni Grassi; P M Shah
Journal:  Infection       Date:  1992       Impact factor: 3.553

6.  Cefodizime: the Japanese clinical experience.

Authors:  K Matsumoto
Journal:  Infection       Date:  1992       Impact factor: 3.553

7.  In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.

Authors:  H Saito; H Tomioka; K Sato; S Dekio
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

8.  Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.

Authors:  H Gnarpe; J Belsheim; C Blomqvist; A Lundbäck
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Effect of ciprofloxacin on phagocytosis.

Authors:  A Forsgren; P I Bergkvist
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

10.  Pharmacokinetics of cefpimizole in normal humans after single- and multiple-dose intravenous infusions.

Authors:  D B Lakings; J M Friis; R J Brown; H R Allen
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.